Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AVITA Medical Inc RCEL

Healthcare Biotechnology
AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile... see more

Recent & Breaking News (NDAQ:RCEL)

First Patient Enrolled in AVITA Medical's Pivotal Study Evaluating RECELL® System for Pediatric Scald Injuries

Business Wire March 4, 2020

AVITA Medical to Attend the 2020 BTIG Healthcare Conference

Business Wire March 3, 2020

First Patient Enrolled in AVITA Medical's Pivotal Study Evaluating RECELL System for Soft Tissue Reconstruction

Business Wire March 2, 2020

AVITA Medical Half-Year Financial Report for Fiscal 2020

Business Wire February 19, 2020

AVITA Medical to Present at the Cowen 40th Annual Health Care Conference

Business Wire February 11, 2020

AVITA Medical Reports Second Quarter Fiscal 2020 Financial Results and Company Update

Business Wire January 30, 2020

AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Clinical Feasibility Study to Evaluate RECELL System for Vitiligo

Business Wire December 29, 2019

AVITA Medical and the Gates Center for Regenerative Medicine at the University of Colorado Anschutz Medical Campus Enter into Collaboration to Explore Potential Spray-On Treatment of Genetically Modified Cells for Epidermolysis Bullosa

Business Wire November 24, 2019

AVITA Medical Names David McIntyre as Chief Financial Officer

Business Wire November 17, 2019

AVITA Medical Announces Institutional Placement of A$120.0 Million to Support Commercial Growth and Pipeline Development

Business Wire November 12, 2019

AVITA Medical Added to S&P/ASX 200 Index

Business Wire November 7, 2019

AVITA Medical Reports First Quarter Fiscal 2020 Financial Results and Company Update

Business Wire October 30, 2019

AVITA Medical Announces Listing on Nasdaq

Business Wire September 30, 2019

New Data Published in Aesthetic Plastic Surgery Explores the Use of the RECELL System in Combination with Dermabrasion to Treat Acne Scars

Business Wire September 18, 2019

AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Pivotal Study Evaluating RECELL System for Soft Tissue Reconstruction

Business Wire September 16, 2019

AVITA Medical Added to the S&P/ASX 300 Index

Business Wire September 6, 2019

AVITA Medical Reports Fourth Quarter Fiscal 2019 Financial Results and Company Update

Business Wire July 30, 2019

RECELL® System Feasibility Study Results for Treatment of Diabetic Foot Ulcers Presented at 11th Annual Congress of the Japanese Society of Limb Salvage & Podiatric Medicine

Business Wire June 30, 2019

AVITA Medical Announces RECELL® System Preliminary Data Focused on Vitiligo and Facial Acne Scars at the 24th Annual World Congress of Dermatology

Business Wire June 11, 2019

AVITA Medical Appoints Interim CFO

Business Wire May 14, 2019